Table 1.
Predicted human absorbed doses for 18F-FIMP (MIRD method).
| Organ | Estimated absorbed dose (μSV/MBq) | |
|---|---|---|
| Male | Female | |
| Adrenals | 23.7 ± 7.0 | 29.5 ± 8.7 |
| Brain | 9.5 ± 0.4 | 12.1 ± 0.5 |
| Breasts | 10.5 ± 1.4 | 13.2 ± 1.7 |
| Gallbladder Wall | 29.0 ± 13.4 | 34.7 ± 16.2 |
| Gastrointestinal tract | ||
| Stomach Wall | 19.2 ± 2.7 | 24.1 ± 3.6 |
| Small Intestine | 15.8 ± 7.0 | 18.4 ± 2.5 |
| Upper Large Intestine Wall | 16.5 ± 3.1 | 20.7 ± 3.8 |
| Lower Large Intestine Wall | 13.8 ± 0.7 | 17.5 ± 0.8 |
| Heart Wall | 16.7 ± 3.5 | 21.4 ± 4.9 |
| Kidneys | 64.7 ± 26.5 | 71.4 ± 28.9 |
| Liver | 86.3 ± 80.4 | 115 ± 103 |
| Lungs | 14.3 ± 3.2 | 18.7 ± 4.3 |
| Muscle | 12.5 ± 1.3 | 15.5 ± 1.6 |
| Ovaries | 18.1 ± 1.1 | |
| Pancreas | 268 ± 137 | 299 ± 152 |
| Red Marrow | 12.6 ± 1.6 | 15.2 ± 1.8 |
| Osteogenic Cells | 18.1 ± 1.2 | 23.7 ± 1.6 |
| Skin | 9.3 ± 0.8 | 11.6 ± 1.0 |
| Spleen | 18.7 ± 2.2 | 23.4 ± 2.7 |
| Testes | 11.0 ± 0.5 | |
| Thymus | 12.2 ± 1.1 | 15.7 ± 1.4 |
| Thyroid | 11.2 ± 0.5 | 13.1 ± 0.6 |
| Urinary Bladder Wall | 41.3 ± 7.1 | 53.6 ± 9.9 |
| Uterus | 18.9 ± 1.3 | |
| Total Body | 15.0 ± 3.3 | 18.8 ± 4.2 |
| Effective doses | 25.1 ± 5.3 | 30.8 ± 6.7 |